VIA

Virtus Investment Advisers Portfolio holdings

AUM $349M
1-Year Est. Return 25.41%
This Quarter Est. Return
1 Year Est. Return
+25.41%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$296M
AUM Growth
-$72M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
512
New
Increased
Reduced
Closed

Top Buys

1
+$2.01M
2
+$1.82M
3
+$1.75M
4
CSCO icon
Cisco
CSCO
+$1.7M
5
STT icon
State Street
STT
+$1.69M

Top Sells

1
+$32.2M
2
+$24.6M
3
+$19M
4
SMC
Summit Midstream
SMC
+$3.67M
5
JNK icon
State Street SPDR Bloomberg High Yield Bond ETF
JNK
+$2.09M

Sector Composition

1 Financials 33.24%
2 Healthcare 17.43%
3 Technology 12.41%
4 Industrials 9.1%
5 Consumer Discretionary 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNTA
326
Centessa Pharmaceuticals
CNTA
$3.71B
$103K 0.03%
7,810
-1,923
ABCL icon
327
AbCellera Biologics
ABCL
$1.1B
$102K 0.03%
29,852
-25,793
NUVB icon
328
Nuvation Bio
NUVB
$1.67B
$101K 0.03%
51,952
-10,469
SANA icon
329
Sana Biotechnology
SANA
$1.06B
$101K 0.03%
37,021
-43,446
MLTX icon
330
MoonLake Immunotherapeutics
MLTX
$905M
$101K 0.03%
2,136
-914
MBX
331
MBX Biosciences
MBX
$1.11B
$100K 0.03%
8,772
+766
SRRK icon
332
Scholar Rock
SRRK
$3.6B
$100K 0.03%
2,822
-1,117
CELC icon
333
Celcuity
CELC
$3.93B
$100K 0.03%
7,487
-5,533
EYPT icon
334
EyePoint Pharmaceuticals
EYPT
$959M
$99.9K 0.03%
10,613
-10,061
AUTL
335
Autolus Therapeutics
AUTL
$365M
$99.7K 0.03%
43,736
-17,291
XERS icon
336
Xeris Biopharma Holdings
XERS
$1.19B
$99.3K 0.03%
21,274
-27,014
SMMT icon
337
Summit Therapeutics
SMMT
$13.4B
$99.3K 0.03%
4,664
-4,528
ORIC icon
338
Oric Pharmaceuticals
ORIC
$1.19B
$98.7K 0.03%
9,724
-9,749
OLMA icon
339
Olema Pharmaceuticals
OLMA
$577M
$98.7K 0.03%
23,161
-1,266
VERA icon
340
Vera Therapeutics
VERA
$1.81B
$98.4K 0.03%
4,176
+539
SLNO icon
341
Soleno Therapeutics
SLNO
$2.65B
$98.2K 0.03%
1,172
-2,371
SLN
342
Silence Therapeutics
SLN
$323M
$97.7K 0.03%
16,837
-8,035
ARQT icon
343
Arcutis Biotherapeutics
ARQT
$3.06B
$97.6K 0.03%
6,965
-6,436
APGE icon
344
Apogee Therapeutics
APGE
$4.47B
$97.5K 0.03%
2,246
-1,455
ARCT icon
345
Arcturus Therapeutics
ARCT
$207M
$96.8K 0.03%
7,439
-1,914
PHVS icon
346
Pharvaris
PHVS
$1.53B
$96K 0.03%
5,457
-3,179
SION
347
Sionna Therapeutics
SION
$1.65B
$96K 0.03%
+5,535
ETNB
348
DELISTED
89bio
ETNB
$96K 0.03%
9,775
-11,137
RAPP
349
Rapport Therapeutics
RAPP
$1.16B
$96K 0.03%
8,441
-196
ELVN icon
350
Enliven Therapeutics
ELVN
$1.31B
$95.9K 0.03%
4,783
-2,359
12 13
14
15 16